HEMISPHERX BIOPHARMA INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - May 7, 2012

Attached files
FileFilename
EXCEL - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR8.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR2.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR4.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR1.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR6.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR3.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR9.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR16.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR22.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR18.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR15.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR21.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR10.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR17.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR12.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR13.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR20.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR14.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR19.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR11.htm
EX-31.1 - EXHIBIT 31.1 - HEMISPHERX BIOPHARMA INCv311716_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - HEMISPHERX BIOPHARMA INCv311716_ex32-2.htm
EX-31.2 - EXHIBIT 31.2 - HEMISPHERX BIOPHARMA INCv311716_ex31-2.htm
10-Q - FORM 10-Q - HEMISPHERX BIOPHARMA INCv311716_10q.htm
XML - IDEA: XBRL DOCUMENT - HEMISPHERX BIOPHARMA INCR7.htm
EX-32.1 - EXHIBIT 32.1 - HEMISPHERX BIOPHARMA INCv311716_ex32-1.htm
v2.4.0.6
Consolidated Statements of Changes in Stockholders' Equity and Comprehensive Income (Loss) (USD $)
In Thousands, except Share data
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2010 $ 135 $ 264,511 $ (974) $ (217,725) $ 45,947
Balance, Common Stock Shares at Dec. 31, 2010 135,241,609        
Stock issued for settlement of accounts payable, Common Stock Shares 94,198        
Stock issued for settlement of accounts payable   48     48
Equity based compensation, Common Stock Shares 0        
Equity based compensation   27     27
Net comprehensive income (loss)     459 (866) (407)
Balance at Mar. 31, 2011 135 264,586 (515) (218,591) 45,615
Balance, Common Stock Shares at Mar. 31, 2011 135,335,807        
Balance at Dec. 31, 2011 136 264,958 (389) (226,740) 37,965
Balance, Common Stock Shares at Dec. 31, 2011 135,642,303        
Equity based compensation, Common Stock Shares 189,674        
Equity based compensation   36     36
Net comprehensive income (loss)     441 (2,308) (1,867)
Balance at Mar. 31, 2012 $ 136 $ 264,994 $ 52 $ (229,048) $ 36,134
Balance, Common Stock Shares at Mar. 31, 2012 135,831,977        

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by HEMISPHERX BIOPHARMA INC and has no official or unofficial affiliation with HEMISPHERX BIOPHARMA INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.